~~<i id='9AF619F878'><strike id='9AF619F878'><tt id='9AF619F878'><pre id='9AF619F878'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

comprehensive

author：comprehensive 2025-09-29 08:51:00 - browse：39

Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT — Adobe

For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

But don’t take their numbers as gospel, experts warned.

“It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Peter Hotez and the public health issue of online harassment
Next article： STAT series 'Denied by AI' wins major journalism prizes

explore

Wikipedia

hotspot

Wikipedia

entertainment

knowledge

ANDREWYATES/AFPviaGettyImagesInpatientswithstage3lungcancerwhereaparticulargeneticmutationispresenti

WSS

The White House hikes tariffs on plastic syringes made in China

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

ASCO24: AstraZeneca won cancer’s big meeting. Can it fulfill its $80B ambition?

Abbott's new stent may help patients with peripheral artery disease

Cord blood banking comes at a high cost to babies

At ASCO, AstraZeneca reports strong data for breast cancer drug

hotspot

comprehensive

explore

Continuity nursing helped my family in our darkest PICU moments

BMI, flaws aside, is found to be useful estimate of body fat in youth

Wildfire smoke exposes gaps in outdoor worker protections

Readout Newsletter: Biogen, Ionis, Johnson & Johnson news

Dobbs anniversary: the lost opportunity of abortion as health care

Obesity drug from Roche shows promise in early study

United colonoscopy coverage change 'may cost lives,' doctors say

For one rare type of lung cancer, Pfizer pill reduces progression by 81%

Medical leaders decry Supreme Court decision on affirmative action

Novo Nordisk testing Wegovy against alcohol

Wikipedia

Cord blood banking comes at a high cost to babies

Kaiser's Risant Health gobbled up Geisinger. Who is next?

Readout LOUD podcast: ASCO preview, a Duchenne trial failure

With trial win, GSK could get blood cancer drug back on market

Hottest summer in 2,000 years puts focus on extreme heat, health

Supreme Court to hear if Covid misinformation is protected speech

hotspot

Wikipedia

entertainment

knowledge